Differential response of esophageal cancer cells to particle irradiation.


Journal

Radiation oncology (London, England)
ISSN: 1748-717X
Titre abrégé: Radiat Oncol
Pays: England
ID NLM: 101265111

Informations de publication

Date de publication:
08 Jul 2019
Historique:
received: 31 01 2019
accepted: 26 06 2019
entrez: 10 7 2019
pubmed: 10 7 2019
medline: 28 12 2019
Statut: epublish

Résumé

Radiation therapy is a mainstay in the treatment of esophageal cancer (EC) patients, and photon radiotherapy has proved beneficial both in the neoadjuvant and the definitive setting. However, regarding the still poor prognosis of many EC patients, particle radiation employing a higher biological effectiveness may help to further improve patient outcomes. However, the influence of clinically available particle radiation on EC cells remains largely unknown. Patient-derived esophageal adenocarcinoma and squamous cell cancer lines were treated with photon and particle irradiation using clinically available proton ( While both adenocarcinoma EC cell lines demonstrated increasing sensitivities for Esophageal cancer cells exhibit differential responses to irradiation with photons and

Sections du résumé

BACKGROUND BACKGROUND
Radiation therapy is a mainstay in the treatment of esophageal cancer (EC) patients, and photon radiotherapy has proved beneficial both in the neoadjuvant and the definitive setting. However, regarding the still poor prognosis of many EC patients, particle radiation employing a higher biological effectiveness may help to further improve patient outcomes. However, the influence of clinically available particle radiation on EC cells remains largely unknown.
METHODS METHODS
Patient-derived esophageal adenocarcinoma and squamous cell cancer lines were treated with photon and particle irradiation using clinically available proton (
RESULTS RESULTS
While both adenocarcinoma EC cell lines demonstrated increasing sensitivities for
CONCLUSIONS CONCLUSIONS
Esophageal cancer cells exhibit differential responses to irradiation with photons and

Identifiants

pubmed: 31286978
doi: 10.1186/s13014-019-1326-9
pii: 10.1186/s13014-019-1326-9
pmc: PMC6615091
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

119

Références

Mol Cancer Ther. 2008 Sep;7(9):2866-75
pubmed: 18790767
Int J Radiat Oncol Biol Phys. 2014 Jan 1;88(1):175-81
pubmed: 24239385
PLoS One. 2011;6(8):e23427
pubmed: 21858113
Br J Cancer. 2015 Sep 15;113(6):878-85
pubmed: 26291056
Br J Surg. 2011 Jun;98(6):768-83
pubmed: 21462364
Oncotarget. 2015 Aug 14;6(23):19366-80
pubmed: 26203772
Ann Oncol. 2016 Sep;27(suppl 5):v50-v57
pubmed: 27664261
Radiat Oncol. 2014 Aug 29;9:191
pubmed: 25175056
Oncol Rep. 2005 Jun;13(6):1241-6
pubmed: 15870949
JAMA. 1999 May 5;281(17):1623-7
pubmed: 10235156
Ann Surg. 2019 Apr;269(4):663-670
pubmed: 29334555
Cancer. 2017 Nov 1;123(21):4106-4113
pubmed: 28885712
Strahlenther Onkol. 2016 Jul;192(7):458-66
pubmed: 27245818
Oncogene. 2014 Mar 20;33(12):1495-505
pubmed: 23604115
Cancer Lett. 1998 Jan 9;122(1-2):181-6
pubmed: 9464508
Oncogene. 2011 Aug 18;30(33):3585-98
pubmed: 21423218
Radiat Oncol. 2014 Mar 28;9(1):88
pubmed: 24679134
Lancet Oncol. 2015 Feb;16(2):e93-e100
pubmed: 25638685
Cancer. 2015 Sep 1;121(17):3001-9
pubmed: 26043145
Cancer Res. 2004 Oct 1;64(19):7144-9
pubmed: 15466212
Lancet Oncol. 2014 Mar;15(3):305-14
pubmed: 24556041
Int J Hyperthermia. 1998 Mar-Apr;14(2):195-202
pubmed: 9589324
Lancet. 2013 Feb 2;381(9864):400-12
pubmed: 23374478
Radiother Oncol. 2018 Jul;128(1):56-67
pubmed: 29861141
CA Cancer J Clin. 2015 Mar;65(2):87-108
pubmed: 25651787
Oncotarget. 2015 Feb 10;6(4):2076-87
pubmed: 25504442
Int J Radiat Oncol Biol Phys. 1997 Feb 1;37(3):593-9
pubmed: 9112458
Cancer. 2018 May 1;124(9):2036-2044
pubmed: 29469932
J Gerontol A Biol Sci Med Sci. 2011 Apr;66(4):367-75
pubmed: 21081476
N Engl J Med. 2012 May 31;366(22):2074-84
pubmed: 22646630
J Clin Oncol. 2002 Mar 1;20(5):1167-74
pubmed: 11870157

Auteurs

Sarah Hartfiel (S)

Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
Department of Molecular Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Heavy Ion Therapy Center (HIT), Heidelberg University Hospital, Im Neuenheimer Feld 450, 69120, Heidelberg, Germany.

Matthias Häfner (M)

Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
Heavy Ion Therapy Center (HIT), Heidelberg University Hospital, Im Neuenheimer Feld 450, 69120, Heidelberg, Germany.

Ramon Lopez Perez (RL)

Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
Department of Molecular Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Alexander Rühle (A)

Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
Department of Molecular Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Heavy Ion Therapy Center (HIT), Heidelberg University Hospital, Im Neuenheimer Feld 450, 69120, Heidelberg, Germany.

Thuy Trinh (T)

Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
Department of Molecular Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Heavy Ion Therapy Center (HIT), Heidelberg University Hospital, Im Neuenheimer Feld 450, 69120, Heidelberg, Germany.

Jürgen Debus (J)

Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
Heavy Ion Therapy Center (HIT), Heidelberg University Hospital, Im Neuenheimer Feld 450, 69120, Heidelberg, Germany.

Peter E Huber (PE)

Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
Department of Molecular Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Heavy Ion Therapy Center (HIT), Heidelberg University Hospital, Im Neuenheimer Feld 450, 69120, Heidelberg, Germany.

Nils H Nicolay (NH)

Department of Molecular Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany. nils.nicolay@uniklinik-freiburg.de.
Department of Radiation Oncology, University Medical Center Freiburg, University of Freiburg, Robert-Koch-Straße 3, 79106, Freiburg, Germany. nils.nicolay@uniklinik-freiburg.de.
German Cancer Consortium (DKTK) Partner Site Freiburg, German Cancer Research Center (DKFZ), Heidelberg, Germany. nils.nicolay@uniklinik-freiburg.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH